Literature DB >> 24900497

Synthesis of New Hydrophilic and Hydrophobic Cobinamides as NO-Independent sGC Activators.

Keith Ó Proinsias1, Maciej Giedyk1, Iraida G Sharina2, Emil Martin2, Dorota Gryko1.   

Abstract

Herein, the synthesis of novel hydrophobic and hydrophilic cobinamides via aminolysis of vitamin B12 derivatives that activate soluble guanyl cyclase (sGC) is presented. Unlike other sGC regulators, they target the catalytic domain of sGC and show higher activity than (CN)2Cbi.

Entities:  

Keywords:  aminolysis; cobinamide; soluble guanyl cyclase; vitamin B12

Year:  2012        PMID: 24900497      PMCID: PMC4025757          DOI: 10.1021/ml300060n

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  12 in total

1.  YC-1, a novel activator of platelet guanylate cyclase.

Authors:  F N Ko; C C Wu; S C Kuo; F Y Lee; C M Teng
Journal:  Blood       Date:  1994-12-15       Impact factor: 22.113

2.  Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine.

Authors:  C A Gruetter; B K Barry; D B McNamara; D Y Gruetter; P J Kadowitz; L Ignarro
Journal:  J Cyclic Nucleotide Res       Date:  1979

3.  Selective modifications of hydrophobic vitamin B12 derivatives at c-and d-positions.

Authors:  Keith ó Proinsias; Maciej Giedyk; Rafał Loska; Mikołaj Chromiński; Dorota Gryko
Journal:  J Org Chem       Date:  2011-07-26       Impact factor: 4.354

4.  New hydrophobic vitamin B12 derivatives via ring-opening reactions of c-lactone.

Authors:  Keith ó Proinsias; Jonathan L Sessler; Sylwester Kurcoń; Dorota Gryko
Journal:  Org Lett       Date:  2010-10-15       Impact factor: 6.005

Review 5.  Nitric oxide: a unique endogenous signaling molecule in vascular biology.

Authors:  L J Ignarro
Journal:  Biosci Rep       Date:  1999-04       Impact factor: 3.840

6.  Cobinamides are novel coactivators of nitric oxide receptor that target soluble guanylyl cyclase catalytic domain.

Authors:  Iraida Sharina; Michael Sobolevsky; Marie-Francoise Doursout; Dorota Gryko; Emil Martin
Journal:  J Pharmacol Exp Ther       Date:  2011-12-13       Impact factor: 4.030

7.  YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase.

Authors:  C C Wu; F N Ko; S C Kuo; F Y Lee; C M Teng
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

Review 8.  NO- and haem-independent soluble guanylate cyclase activators.

Authors:  Harald H H W Schmidt; Peter M Schmidt; Johannes-Peter Stasch
Journal:  Handb Exp Pharmacol       Date:  2009

Review 9.  Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.

Authors:  Guido Boerrigter; John C Burnett
Journal:  Cardiovasc Drug Rev       Date:  2007

10.  NO-independent regulatory site of direct sGC stimulators like YC-1 and BAY 41-2272.

Authors:  E M Becker; C Alonso-Alija; H Apeler; R Gerzer; T Minuth; U Pleiss; P Schmidt; M Schramm; H Schröder; W Schroeder; W Steinke; A Straub; J P Stasch
Journal:  BMC Pharmacol       Date:  2001-12-28
View more
  1 in total

1.  Vitamin B₁₂ derivatives as activators of soluble guanylyl cyclase.

Authors:  Keith ó Proinsias; Daniel T Gryko; Yoshio Hisaeda; Emil Martin; Jonathan L Sessler; Dorota Gryko
Journal:  J Med Chem       Date:  2012-10-05       Impact factor: 7.446

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.